Crossref
Outcome of rituximab therapy in patients with systemic lupus erythematosus
Annals of Rheumatology and Autoimmunity · 2023
DOI: 10.4103/ara.ara_10_22 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Rheumatology and Autoimmunity, 2023. Verfasst von Hanan Al Rayes und 5 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Rayes, H. A., Alaithan, M., Halabi, H., Shamaa, M., Alharbi, R., & Aljoma, N. (2023). Outcome of rituximab therapy in patients with systemic lupus erythematosus. Annals of Rheumatology and Autoimmunity. https://doi.org/10.4103/ara.ara_10_22
Vancouver
Rayes HA, Alaithan M, Halabi H, Shamaa M, Alharbi R, Aljoma N. Outcome of rituximab therapy in patients with systemic lupus erythematosus. Annals of Rheumatology and Autoimmunity. 2023. doi:10.4103/ara.ara_10_22
BibTeX
@article{Rayes2023,
author = {Rayes, Hanan Al and Alaithan, MufaddalAdil and Halabi, Hussein and Shamaa, MaryamMohammed and Alharbi, RawanNaser and Aljoma, NuwarIbrahim},
title = {Outcome of rituximab therapy in patients with systemic lupus erythematosus},
journal = {Annals of Rheumatology and Autoimmunity},
year = {2023},
doi = {10.4103/ara.ara_10_22}
}
EUVIMED